Secora Michael — SEC Form 4 filings
SEC reporting owner CIK 1855980. 15 Form 4 filings on record with FilingPulse; latest filed 2024-11-19.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-01-18 to 2024-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 10 filings — 378,124 shares, $3,224,221 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 48.
- Largest priced transaction: sale of 25,000 shares @ $11.03 ($275,815) in RECURSION PHARMACEUTICALS, INC., filed 2024-03-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 15 | — | 21 legs · 378,124 sh · $3,224,221 | 48 |
Form 4 filings — Secora Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-11-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 11,937 @ $6.17 | EDGAR |
| 2024-11-14 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $7.64 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $7.66 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-10-10 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.32 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.36 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.17 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.32 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 11,962 @ $6.69 | EDGAR |
| 2024-08-15 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.35 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $6.35 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-07-11 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $7.32 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $7.24 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $9.32 · Option exercise (M): 39,375 @ $2.22 · Sale (S): 15,000 @ $9.27 · Option exercise (M): 39,375 (derivative) @ $0 · Option exercise (M): 39,375 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 11,962 @ $10.01 | EDGAR |
| 2024-04-18 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $7.67 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 23,124 @ $7.58 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2024-03-14 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $10.46 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $11.03 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 7,172 @ $12.43 | EDGAR |
| 2024-02-15 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $9.86 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 23,933 @ $10.43 · Sale (S): 1,067 @ $10.98 · Option exercise (M): 37,500 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-13 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 8,659 @ $0 · Grant/award (A): 174,190 @ $0 · Tax withholding (F): 2,512 @ $10.09 · Grant/award (A): 348,380 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $10.45 · Option exercise (M): 37,500 @ $2.22 · Sale (S): 25,000 @ $10.25 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1855980 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →